SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

China to Add AstraZeneca’s Tezspire to Health Insurance Scheme

China’s National Healthcare Security Administration says AstraZeneca’s asthma drug Tezspire will be added to the country’s health insurance scheme.

Related stories